Peritoneal dialysis is not associated with myocardial stunning

Peritoneal Dialysis International

Volumn 31, Issue 1, 2011, Pages 27-33

  Selby, Nicholas M ^a   McIntyre, Christopher W ^a,b  

^a ROYAL DERBY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Hemodynamics; Ischemia; Myocardial stunning

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY DISEASE; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; STUNNED HEART MUSCLE; THERAPY EFFECT; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; MIDDLE AGED;

ADULT; AGED; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL STUNNING; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84855178661     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2010.00007     Document Type: Article

References (42)

1. Parfrey PS. Pathogenesis of cardiac disease in dialysis patients. Semin Dial 1999; 12:62-8.
2. Van Biesen W, Vanholder R, Verbeke F, Lameire N. Is peritoneal dialysis associated with increased cardiovascular morbidity and mortality? Perit Dial Int 2006; 26:429-34.
3. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl 2006; (103):S3-11.
4. Selby NM, Burton JO, Chesterton LJ, McIntyre CW. Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol 2006; 1:1216-25.
5. Selby NM, Lambie SH, Camici PG, Baker CS, McIntyre CW. Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis 2006; 47:830-41.
6. McIntyre CW, Burton JO, Selby NM, Leccisotti L, Korsheed S, Baker CSR, et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 2008; 3:19-26.
7. Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 2009; 4:914-20. Epub 8 Apr 2009 as doi:10.2215/CJN.03900808.
8. Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 2009; 4:1925-31. Epub 1 Oct 2009 as doi:10.2215/CJN.04470709.
9. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int 2004; 65:2380-9.
10. Ohtake T, Kobayashi S, Moriya H, Negishi K, Okamoto K, Maegato K, et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol 2005; 16:1141-8.
11. Ragosta M, Samady H, Isaacs RB, Gimple LW, Sarembock IJ, Powers ER. Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. Am Heart J 2004; 147:1017-23.
12. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47:186-92.
13. Schumann L, Korten G, Holdt B, Holtz M. Microcirculation of the fingernail fold in CAPD patients: preliminary observations. Perit Dial Int 1996; 16:412-16.
14. Sigrist MK, McIntyre CW. Vascular calcification is associated with impaired microcirculatory function in chronic haemodialysis patients. Nephron Clin Pract 2008; 108: 121-6.
15. Boon D, Bos WJ, van Montfrans GA, Krediet RT. Acute effects of peritoneal dialysis on hemodynamics. Perit Dial Int 2001; 21:166-71.
16. Ivarsen P, Povlsen JV, Jensen JD. Increasing fill volume reduces cardiac performance in peritoneal dialysis. Nephrol Dial Transplant 2007; 22:2999-3004.
17. Pletinck A, Verbeke F, Van Bortel L, Dequidt C, Vijt D, Van Biesen W, et al. Acute central haemodynamic effects induced by intraperitoneal glucose instillation. Nephrol Dial Transplant 2008; 23:4029-35.
18. Selby NM, Fialova J, Burton JO, McIntyre CW. The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids. Nephrol Dial Transplant 2007; 22:870-9.
19. Selby NM, Fonseca S, Hulme L, Fluck RJ, Taal MW, McIntyre CW. Hypertonic glucose-based peritoneal dialysate is associated with higher blood pressure and adverse haemodynamics as compared with icodextrin. Nephrol Dial Transplant 2005; 20:1848-53.
20. Selby NM, Fonseca S, Hulme L, Fluck RJ, Taal MW, McIntyre CW. Automated peritoneal dialysis has significant effects on systemic hemodynamics. Perit Dial Int 2006; 26: 328-35.
21. Verbeke F, Van Biesen W, Pletinck A, Van Bortel LM, Vanholder R. Acute central hemodynamic effects of a volume exchange in peritoneal dialysis. Perit Dial Int 2008; 28:142-8.
22. Van Biesen W, Pletinck A, Verbeke F, Vanholder R. Acute central hemodynamic effects of peritoneal dialysis. Contrib Nephrol 2009; 163:96-101.
23. Bosch JG, Savalle LH, van Burken G, Reiber JH. Evaluation of a semiautomatic contour detection approach in sequences of short-axis two-dimensional echocardiographic images. J Am Soc Echocardiogr 1995; 8:810-21.
24. Schneditz D, Bachler I, Stadlbauer V, Stauber RE. Albumin infusion fails to restore circulatory function following paracentesis of tense ascites as assessed by beat-to-beat haemodynamic measurements. Int J Clin Pract 2007; 62: 1851-7.
25. Zuber M, Steinmann E, Huser B, Ritz R, Thiel G, Brunner F. Incidence of arrhythmias and myocardial ischaemia during haemodialysis and haemofiltration. Nephrol Dial Transplant 1989; 4:632-4.
26. Dasselaar JJ, Slart RHJA, Knip M, Pruim J, Tio RA, McIntyre CW, et al. Haemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrol Dial Transplant 2009; 24:604-10.
27. Foley RN, Parfrey PS, Harnett JD, Kent GM, O'Dea R, Murray DC, et al. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol 1998; 9:267-76.
28. Locatelli F, Marcelli D, Conte F, D'Amico M, del Vecchio L, Limido A, et al. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol 2001; 12:2411-17.
29. Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003; 14:415-24.
30. Piraino B. Cardiovascular complications in peritoneal dialysis patients. Contrib Nephrol 2009; 163:102-9.
31. Marshall J, Jennings P, Scott A, Fluck RJ, McIntyre CW. Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int 2003; 64:1480-6.
32. Zeier M, Schwenger V, Deppisch R, Haug U, Weigel K, Bahner U, et al. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 2003; 63:298-305.
33. Kocak H, Gumuslu S, Sahin E, Ceken K, Gocmen AY, Yakupoglu G, et al. Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients. Nephrology 2009; 14: 273-80.
34. Posthuma N, ter Wee PM, Niessen H, Donker AJ, Verbrugh HA, Schalkwijk CG. Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin. Perit Dial Int 2001; 21:43-51.
35. Schmitt CP, von Heyl D, Rieger S, Arbeiter K, Bonzel KE, Fischbach M, et al. Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content. Nephrol Dial Transplant 2007; 22:2038-44.
36. Szeto CC, Kwan BCH, Chow KM, Lai KB, Chung KY, Leung CB, et al. Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol 2008; 3:431-6.
37. Hothi DK, Rees L, Marek J, Burton J, McIntyre CW. Pediatric myocardial stunning underscores the cardiac toxicity of conventional hemodialysis treatments. Clin J Am Soc Nephrol 2009; 4:790-7.
38. Eliasen P. Determinants of regional myocardial oxygen supply in the left ventricle. An experimental study in situ in the working canine heart. Dan Med Bull 1987; 34: 277-89.
39. Converse RL Jr, Jacobsen TN, Jost CM, Toto RD, Grayburn PA, Obregon TM, et al. Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest 1992; 90:1657-65.
40. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 2008; 88:1009-86.
41. Shim WS, Lim SY, Li SQ, Gu Y, Ong HC, Song IC, et al. Structural stability of neoangiogenic intramyocardial microvessels supports functional recovery in chronic ischemic myocardium. J Mol Cell Cardiol 2008; 45:70-80.
42. McIntyre NJ, Chesterton LJ, Taal MW, Fluck RJ, McIntyre CW. Tissue advanced glycation end product concentration in dialysis patients. Clin J Am Soc Nephrol 2010; 5:51-5.